Menna, Pierantonio
Menna, Pierantonio
Adjudication of Adverse Cardiovascular Events in Patients with Chronic Lymphocytic Leukaemia Treated with Ibrutinib: Deaths in GLOW or Blowing in the Wind?
2025 Esposito, Roberta; Menna, Pierantonio; Salvatorelli, Emanuela; Camilli, Massimiliano; Minotti, Giorgio
Advances in Bruton tyrosine kinase (Btk) inhibition are steered by Bruton tyrosine kinase phylogeny
2025 Minotti, Giorgio; Camilli, Massimiliano; Salvatorelli, Emanuela; Menna, Pierantonio
Anthracyclines, Diastolic Dysfunction and the road to Heart Failure in Cancer survivors: An untold story
2024 Camilli, Massimiliano; Ferdinandy, P.; Salvatorelli, E.; Menna, Pierantonio; Minotti, G.
Beyond hypertension: Diastolic dysfunction associated with cancer treatment in the era of cardio-oncology
2022 Minotti, G.; Menna, Pierantonio; Camilli, Massimiliano; Salvatorelli, E.; Levi, R.
Cardiac Anthracycline Accumulation and B-Type Natriuretic Peptide to Define Risk and Predictors of Cancer Treatment–Related Early Diastolic Dysfunction
2022 Minotti, G.; Salvatorelli, E.; Reggiardo, G.; Mangiacapra, F.; Camilli, Massimiliano; Menna, Pierantonio
From Cardiac Anthracycline Accumulation to Real-Life Risk for Early Diastolic Dysfunction: A Translational Approach
2022 Minotti, G.; Reggiardo, G.; Camilli, Massimiliano; Salvatorelli, E.; Menna, Pierantonio
Predictors of early or delayed diastolic dysfunction after anthracycline-based or nonanthracycline chemotherapy: A pharmacological appraisal
2021 Minotti, G.; Menna, Pierantonio; Camilli, Massimiliano; Salvatorelli, E.; Reggiardo, G.
In ®Entresto we trust
2020 Camilli, Massimiliano; Del Buono, Marco Giuseppe; Menna, Pierantonio; Minotti, Giorgio